<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2340-9894</journal-id>
<journal-title><![CDATA[Ars Pharmaceutica (Internet)]]></journal-title>
<abbrev-journal-title><![CDATA[Ars Pharm]]></abbrev-journal-title>
<issn>2340-9894</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Granada]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2340-98942019000600231</article-id>
<article-id pub-id-type="doi">10.30827/ars.v60i4.8517</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Proliposomes: an approach for the development of stable liposome]]></article-title>
<article-title xml:lang="es"><![CDATA[Proliposomas: una aproximación para el desarrollo de liposoma estables]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[Namita]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Kushwaha]]></surname>
<given-names><![CDATA[Poonam]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ahmad]]></surname>
<given-names><![CDATA[Usama]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Abdullah]]></surname>
<given-names><![CDATA[Mohammad]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Integral University Faculty of Pharmacy ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>India</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>60</volume>
<numero>4</numero>
<fpage>231</fpage>
<lpage>240</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2340-98942019000600231&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2340-98942019000600231&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2340-98942019000600231&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Background: For several years, many attempts have been made for the improvement of liposomal stability. In 1986, Payne et al, introduced the concept of Pro-liposome for liposome preparation in order to avoid physicochemical instability encountered in some liposome suspensions such as aggregation, fusion, hydrolysis, and/or oxidation.  Objective:  The objective of this review is to focus on different aspects related to Proliposomes, their method of preparation, characterization techniques and pointing out its scope in drug delivery systems.  Methods:  Proliposomes are a new form of drug delivery systems. They are dry, free-flowing granular products composed of drug and phospholipid which, upon addition of water, disperse to form a multi-lamellar liposomal suspension.  Results and Discussion: These Proliposomes are nearly as good as or perhaps better than conventional liposomes. In the present review attempt has been made to briefly explain the concept of Proliposomes with a focus on its components, preparation, characterizations and their field of application.  Conclusion: Extensive survey of literatures and collected data suggests that Pro-liposomes are promising drug carriers for the future.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Antecedentes:  durante varios años, se han realizado muchos intentos para mejorar la estabilidad liposomal. En 1986, Payne et al, introdujeron el concepto de pro-liposoma para la preparación de liposoma con el fin de evitar la inestabilidad fisicoquímica encontrada en algunas suspensiones de liposoma tales como agregación, fusión, hidrólisis, y/o oxidación.  Objetivo:  el objetivo de esta revisión es centrarse en diferentes aspectos relacionados con los Proliposomas, su método de preparación, técnicas de caracterización, asi como señalar su alcance en los sistemas de administración de fármacos.  Métodos:  los Proliposomas son una nueva forma de sistemas de administración de fármacos. Son productos granulares secos y de flujo libre compuestos por fármacos y fosfolípidos que, al añaderse el agua, se dispersan para formar una suspensión liposomal multilamelar.  Resultados y discusión:  estos Proliposomas son casi tan buenos o quizás mejores que los liposomas convencionales. En la presente revisión se explica brevemente el concepto de Proliposomas con un enfoque en sus componentes, preparación, caracterizaciones y su campo de aplicación.  Conclusión:  una extensa encuesta de literaturas y datos recogidos sugiere que los pro-liposomas son portadores de fármacos prometedores para el futuro.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Liposoma]]></kwd>
<kwd lng="es"><![CDATA[Proliposoma]]></kwd>
<kwd lng="es"><![CDATA[Estabilidad]]></kwd>
<kwd lng="es"><![CDATA[Biodisponibilidad]]></kwd>
<kwd lng="es"><![CDATA[Fosfolipido]]></kwd>
<kwd lng="es"><![CDATA[Colesterol]]></kwd>
<kwd lng="en"><![CDATA[Liposome]]></kwd>
<kwd lng="en"><![CDATA[Proliposome]]></kwd>
<kwd lng="en"><![CDATA[Stability]]></kwd>
<kwd lng="en"><![CDATA[Bioavailability]]></kwd>
<kwd lng="en"><![CDATA[Phospholipid]]></kwd>
<kwd lng="en"><![CDATA[Cholesterol]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Liposome: Classification, preparation, and applications]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Akbarzadeh]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rezaei-Sadabady]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Davaran]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Joo]]></surname>
<given-names><![CDATA[SW]]></given-names>
</name>
<name>
<surname><![CDATA[Zarghami]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hanifehpour]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Samiei]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kouhi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[NejatiKoshki]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Nanoscale Res Lett]]></source>
<year>2013</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>102-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vyas]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Khar]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Liposome]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Vyas]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
</person-group>
<source><![CDATA[Targeted and controlled drug delivery (Novel carrier systems)]]></source>
<year>2006</year>
<edition>2</edition>
<page-range>173-81</page-range><publisher-loc><![CDATA[New Delhi ]]></publisher-loc>
<publisher-name><![CDATA[CBS publishers and distributors]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[New]]></surname>
<given-names><![CDATA[RRC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preparation of liposomes]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[New]]></surname>
<given-names><![CDATA[RRC]]></given-names>
</name>
</person-group>
<source><![CDATA[Liposomes: a practical approach]]></source>
<year>1990</year>
<edition>2nd</edition>
<page-range>36-9</page-range><publisher-loc><![CDATA[Oxford-New York ]]></publisher-loc>
<publisher-name><![CDATA[IRL Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proliposome: Novel drug delivery system]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parmar]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bala]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Seth]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Banerjee]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[World J Pharm Res]]></source>
<year>2015</year>
<volume>4</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>679-92</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proliposomes as Pharmaceutical Drug Delivery System: A Brief Review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muneer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Masood]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Butt]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Anjum]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Zainab]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[J Nanomed Nanotechnol]]></source>
<year>2017</year>
<volume>8</volume>
<page-range>448-50</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Characterization of proliposomes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Payne]]></surname>
<given-names><![CDATA[NI]]></given-names>
</name>
<name>
<surname><![CDATA[Browning]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Hynes]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<source><![CDATA[J Pharm Sci]]></source>
<year>1986</year>
<volume>75</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>330-3</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proliposomes: A novel approach to carrier drug delivery system]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hiremath]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gowda]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Raj]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Shamant]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
<name>
<surname><![CDATA[Srivastava]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[J Chem Pharm Res]]></source>
<year>2016</year>
<volume>8</volume>
<page-range>348-54</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Micronization: A method of improving the bioavailability of poorly soluble drugs]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chaumeil]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<source><![CDATA[Methods Find Exp Clin Pharmacol]]></source>
<year>1998</year>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>211-5</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Use of fluidized bed in proliposome manufacturing]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Alli]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[J Pharm Sci]]></source>
<year>1987</year>
<volume>76</volume>
<page-range>419-20</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Factors affecting microencapsulation of drugs in liposomes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kulkarni]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Betageri]]></surname>
<given-names><![CDATA[GV]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[J Microencapsul]]></source>
<year>1995</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>229-46</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rong]]></surname>
<given-names><![CDATA[LJBC]]></given-names>
</name>
<name>
<surname><![CDATA[Sophia]]></surname>
<given-names><![CDATA[YL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Liposomes in solubilisation]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Water-Insoluble drug formulation]]></source>
<year>2008</year>
<edition>2nd</edition>
<page-range>375-416</page-range><publisher-loc><![CDATA[Boca Raton, FL, USA ]]></publisher-loc>
<publisher-name><![CDATA[CRC Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Betageri]]></surname>
<given-names><![CDATA[GV]]></given-names>
</name>
<name>
<surname><![CDATA[Jenkins]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Parsons]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
</person-group>
<source><![CDATA[Liposome drug delivery systems]]></source>
<year>1993</year>
<publisher-loc><![CDATA[Lancaster ]]></publisher-loc>
<publisher-name><![CDATA[Technomic Pub]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Formulation development and in vitro characterization of proliposomes for topical delivery]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Barupal]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Ramteke]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Indian J Pharm Sci]]></source>
<year>2008</year>
<volume>70</volume>
<page-range>768-75</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluation of potential hypoglycemic activity of proliposomal gel containing Metformin hydrochloride]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shruthi]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Parthiban]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Senthilkumar]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Tamizmani]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Asian J Res Biol Pharm Sci]]></source>
<year>2014</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>77-88</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Phospholipid dry powders produced by spray drying processing structural, thermodynamic and physical properties]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Santana]]></surname>
<given-names><![CDATA[MHA]]></given-names>
</name>
</person-group>
<source><![CDATA[Pow Tech]]></source>
<year>2004</year>
<volume>145</volume>
<page-range>139-48</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proliposomes: A brief overview of novel delivery system]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shaji]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bhatia]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Int Pharm Bio Sci]]></source>
<year>2013</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>150-60</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Preparation of lutein proliposomes by supercritical anti-solvent technique]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xia]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Jin]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Liang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Food Hydrocolloids]]></source>
<year>2012</year>
<volume>26</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>456-63</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Supercritical antisolvent-based technology for preparation of vitamin D3 proliposome and its characteristics]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fei]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Heyang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Yaping]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Xinqiu]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Chinese J Chem Eng]]></source>
<year>2011</year>
<volume>19</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1039-46</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Preparation and evaluation of proliposomes containing salmon calcitonin]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[KH]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Shim]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
</person-group>
<source><![CDATA[Journal of Controlled Release]]></source>
<year>2002</year>
<volume>84</volume>
<page-range>27-37</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leigh]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Supra Vail Vaginal Gel]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Rathbone]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hadgraft]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<source><![CDATA[Modified-Release Drug Delivery Technology]]></source>
<year>2003</year>
<page-range>791-800</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Marcel Dekker]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proniosome based transdermal delivery of levonorgesterel for effective contraception]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vora]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Khopade]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
</person-group>
<source><![CDATA[J Control Release]]></source>
<year>1998</year>
<volume>54</volume>
<page-range>149-65</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Potluri]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Betageri]]></surname>
<given-names><![CDATA[GV]]></given-names>
</name>
</person-group>
<source><![CDATA[Drug Deliv]]></source>
<year>2006</year>
<volume>13</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>227-32</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bobbala]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Veerareddy]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
</person-group>
<source><![CDATA[J Liposome Res]]></source>
<year>2012</year>
<volume>22</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>285-94</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Preparation and characterization of liposomes as therapeutic delivery systems: a review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vemuri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rhodes]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Pharm Ac Hel]]></source>
<year>1995</year>
<volume>70</volume>
<page-range>95-111</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Liposomes preparation methods]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Riaz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Pak J Pharm Sci]]></source>
<year>1996</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>65-77</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muller]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Radtke]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wissing]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<source><![CDATA[Adv Drug Deliv Rev]]></source>
<year>2002</year>
<volume>54</volume>
<page-range>131-55</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proliposomes of indomethacin for oral administration]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Katare]]></surname>
<given-names><![CDATA[OP]]></given-names>
</name>
<name>
<surname><![CDATA[Vyas]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Dixit]]></surname>
<given-names><![CDATA[VK]]></given-names>
</name>
</person-group>
<source><![CDATA[J Microencapsul]]></source>
<year>1991</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Stability aspects of liposomes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yadav]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Murthy]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Shete]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Sakhare]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Ind J Pha Edu Res]]></source>
<year>2011</year>
<volume>45</volume>
<page-range>402-13</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Tong]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Acta Pharmacol Sin]]></source>
<year>2011</year>
<volume>32</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>973-80</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Formulation and evaluation of domperidone oral proliposomal powders]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dhurke]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Nalla]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Bagam]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Eedara]]></surname>
<given-names><![CDATA[BB]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J PharmTech Res]]></source>
<year>2015</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>108-18</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Liquid proliposomes of Nimodipine drug delivery system: Preparation, characterization, and pharmacokinetic]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chuandi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ji]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Jianping]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wenli]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<source><![CDATA[AAPS Pharm Sci Tech]]></source>
<year>2013</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>332-8</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proliposome-based transdermal delivery of levonorgestrel]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Deo]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Sant]]></surname>
<given-names><![CDATA[VP]]></given-names>
</name>
<name>
<surname><![CDATA[Parekh]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Khopade]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Banakar]]></surname>
<given-names><![CDATA[UV]]></given-names>
</name>
</person-group>
<source><![CDATA[J Biomat App]]></source>
<year>1997</year>
<volume>12</volume>
<page-range>77-88</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Enhanced bioavailability of exemestane via proliposomes based transdermal delivery]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jukanti]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sheela]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bandari]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Veerareddy]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
</person-group>
<source><![CDATA[J Pharm Sci]]></source>
<year>2011</year>
<volume>100</volume>
<page-range>3208-22</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
</person-group>
<source><![CDATA[Controlled and novel drug delivery]]></source>
<year>2003</year>
<publisher-loc><![CDATA[Delhi ]]></publisher-loc>
<publisher-name><![CDATA[CBS publishers and distributors]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[In vitro skin permeation of nicotine from proliposomes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hwang]]></surname>
<given-names><![CDATA[BY]]></given-names>
</name>
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Shim]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
</person-group>
<source><![CDATA[J Control Release]]></source>
<year>1997</year>
<volume>49</volume>
<page-range>177-84</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Formulation and Evaluation of Proliposomal Gel Containing Repaglinide Using Mannitol as Water Soluble Carrier]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kumara]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
<name>
<surname><![CDATA[Parthiban]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Senthil-Kumar]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Tamiz-Mani]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Imperial Journal of Interdisciplinary Research]]></source>
<year>2016</year>
<volume>2</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1777-86</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Formulation and Evaluation of Prednisolone Proliposomal Gel for Effective Topical Pharmacotherapy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurakula]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Srinivas]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kasturi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Diwan]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Pharm Sci Drug Res]]></source>
<year>2012</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>35-43</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Piroxicam proliposomal gel -A novel approach for topical delivery]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurakula]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pasula]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[J Pharm Res]]></source>
<year>2012</year>
<volume>5</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1755</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Preparation and evaluation of proliposomes containing Clotrimazole]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ning]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
<name>
<surname><![CDATA[Guo]]></surname>
<given-names><![CDATA[YZ]]></given-names>
</name>
<name>
<surname><![CDATA[Pan]]></surname>
<given-names><![CDATA[HZ]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
</person-group>
<source><![CDATA[Chem Pharm bull]]></source>
<year>2005</year>
<volume>53</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>620-4</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Development of Spray Dried Liposomal Dry Powder Inhaler of Dapsone]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chougule]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Padhi]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Misra]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[AAPS Pharm Sci Tech]]></source>
<year>2008</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>47-53</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Vesicular systems in ocular drug delivery: an overview]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaur]]></surname>
<given-names><![CDATA[PI]]></given-names>
</name>
<name>
<surname><![CDATA[Garg]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Singla]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Pharm]]></source>
<year>2004</year>
<volume>269</volume>
<page-range>1-14</page-range></nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Preparation and evaluation of cyclosporin a-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karn]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[HD]]></given-names>
</name>
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Jin]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Hwang]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Nanomed]]></source>
<year>2014</year>
<volume>9</volume>
<page-range>5079-91</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Nanomedicine in pulmonary delivery]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mansour]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Rhee]]></surname>
<given-names><![CDATA[YS]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Nanomed]]></source>
<year>2009</year>
<volume>4</volume>
<page-range>299-319</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Levofloxacin-Proliposomes: Opportunities for use in lung Tuberculosis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojanarat]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Nakpheng]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Thawithong]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Yanyium]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Pharmaceutics]]></source>
<year>2012</year>
<volume>4</volume>
<page-range>385-412</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Single step spray drying method to develop proliposomes for inhalation: A systematic study based on quality by design approach]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patil]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pokharkar]]></surname>
<given-names><![CDATA[GV]]></given-names>
</name>
</person-group>
<source><![CDATA[Pulmonary Pharmacol Therapeutics]]></source>
<year>2014</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>197-207</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Isoniazid Proliposome Powders for Inhalation-Preparation, Characterization and Cell Culture Studies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kajornwongwattana]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Changsan]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Tawithong]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Srichana]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[International Journal of Molecular Sciences]]></source>
<year>2011</year>
<volume>12</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>4414-34</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Development and Evaluation of Inhalational Liposomal System of Budesonide for Better Management of Asthma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parmar]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hegde]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Menon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Indian Journal of Pharmaceutical Sciences]]></source>
<year>2010</year>
<volume>72</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>442-8</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The controlled delivery of drugs to the lung]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zeng]]></surname>
<given-names><![CDATA[XM]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Marriott]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[International Journal of Pharmaceutics]]></source>
<year>1995</year>
<volume>124</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>149-64</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives, Adv Drug Del]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ugwoke]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Agu]]></surname>
<given-names><![CDATA[RU]]></given-names>
</name>
<name>
<surname><![CDATA[Verbeke]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Kinget]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev]]></source>
<year>2005</year>
<volume>57</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1640-65</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proliposomes as an intranasal dosage form for the sustained delivery of propranolol]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shin]]></surname>
<given-names><![CDATA[BN]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
<name>
<surname><![CDATA[Shim]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Journal of Controlled Release]]></source>
<year>1995</year>
<volume>34</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>203-10</page-range></nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proliposomes as prolonged intranasal drug delivery systems]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Shim]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
</person-group>
<source><![CDATA[STP Pharma Sci]]></source>
<year>2002</year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-8</page-range></nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prolonged delivery of nicotine in rats via nasal administration of proliposomes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Shim]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
</person-group>
<source><![CDATA[J Control Rel]]></source>
<year>2000</year>
<volume>66</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>73-9</page-range></nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The pharmacokinetics of methotrexate after intravenous administration of methotrexate-loaded proliposomes to rats]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Ahn]]></surname>
<given-names><![CDATA[BN]]></given-names>
</name>
<name>
<surname><![CDATA[Yoon]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Shim]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
</person-group>
<source><![CDATA[Biopharm Drug Dispos]]></source>
<year>1994</year>
<volume>15</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>391-407</page-range></nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effervescent granule based proliposomes of ibuprofen]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Katare]]></surname>
<given-names><![CDATA[OP]]></given-names>
</name>
<name>
<surname><![CDATA[Vyas]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Dixit]]></surname>
<given-names><![CDATA[VK]]></given-names>
</name>
</person-group>
<source><![CDATA[J Microencapsul]]></source>
<year>1990</year>
<volume>7</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>455-60</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
